Royal Bank of Canada’s Revelation Biosciences REVB Stock Holding History

Royal Bank of Canada’s Portfolio REVB Stock Details REVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	747	–	–	﹤0.01%	7268
2026 Q1	$1K	Buy	747 +746	+74,600%	+$1.44K	﹤0.01%	6936
2025 Q4	$0	Buy	+1	New	+$4	﹤0.01%	7558
2025 Q3	–	Sell	-285	Closed	-$3K	–	7461
2025 Q2	$3K	Buy	285 +172	+152%	+$4.5K	﹤0.01%	6755
2025 Q1	$4K	Buy	113 +112	+11,200%	+$6.25K	﹤0.01%	6425
2024 Q4	$0	Buy	+1	New	+$133	﹤0.01%	7193
2024 Q3	–	Sell	-6	Closed	-$2K	–	7333
2024 Q2	$2K	Buy	+6	New	+$2.48K	﹤0.01%	6747
2024 Q1	–	Hold	0	–	–	–	7494
2023 Q3	–	Hold	0	–	–	–	7487
2023 Q2	–	Hold	0	–	–	–	7590
2021 Q3	–	Hold	0	–	-$17K	–	7825
2021 Q2	–	Hold	0	–	–	–	6650
2021 Q1	–	Hold	0	–	–	–	6526

Other funds holding REVB

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Royal Bank of Canada's REVB Position: Q2 2026 in Review

Royal Bank of Canada held its Revelation Biosciences (REVB) position steady in Q2 2026 at 747 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #7268.

Royal Bank of Canada first reported a position in REVB in Q2 2024 and has held it in 7 quarters since. The position peaked at $4K in Q1 2025. 12 funds tracked by Wall St. Rank hold REVB as of Q2 2026.

Royal Bank of Canada held 747 shares of Revelation Biosciences worth $1K as of Q2 2026.
Royal Bank of Canada left its Revelation Biosciences share count unchanged in Q2 2026.
Revelation Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7268 holding.
Royal Bank of Canada first reported a position in Revelation Biosciences in Q2 2024 and has held it in 7 quarters since.
Royal Bank of Canada's Revelation Biosciences position peaked at $4K in Q1 2025.
12 funds tracked by Wall St. Rank held Revelation Biosciences as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.